Citi raised the firm’s price target on Veeva (VEEV) to $349 from $329 and keeps a Buy rating on the shares. The firm views the company’s Q2 report as solid with large pharma trends intact.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva Systems: Strong Financial Performance and Strategic Positioning Drive Buy Rating
- Veeva price target raised to $355 from $325 at Piper Sandler
- Veeva price target raised to $341 from $326 at Wells Fargo
- Veeva Systems: Buy Rating Affirmed Amid Strong Q2 Performance and Promising Growth Opportunities
- Veeva Systems Reports Strong Q2 Earnings Growth